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PPrognostic Value of Myocardial Infarct Size and
Contractile Reserve Using Magnetic Resonance Imaging
Sebastian Kelle, MD,* Stijntje D. Roes, MD,† Christoph Klein, MD,* Thomas Kokocinski, MD,*
Albert de Roos, MD,† Eckart Fleck, MD,* Jeroen J. Bax, MD,† Eike Nagel, MD‡
Berlin, Germany; Leiden, the Netherlands; and London, United Kingdom
Objectives Our aim was to assess the predictive value of myocardial infarct size assessed with late gadolinium-enhanced
(LGE) magnetic resonance imaging (MRI) in medically treated patients with chronic myocardial infarction relative
to contractile reserve on low-dose dobutamine magnetic resonance (DSMR) for long-term event-free survival.
Background Information on the relative merits of scar tissue and contractile reserve to predict long-term prognosis in pa-
tients with chronic myocardial infarction is lacking.
Methods A total of 177 patients with known coronary artery disease and scar tissue on LGE MRI were enrolled. Left ven-
tricular (LV) functional parameters at rest and during low-dose DSMR were assessed, and the wall motion score
index was calculated.
Results Eleven patients (6.2%) suffered an event during follow-up (average 20.3 months). Infarct size was a stronger
predictor of events than LV ejection fraction and LV volumes at rest and during low-dose DSMR. Myocardial in-
farct size was used to separate patients at high risk (spatial extent 6 segments, n  98) from those at low risk
(spatial extent 6 segments, n  79) for mortality. In the subgroup of patients at high risk, transmurality of in-
farct was not a predictor of events. However, the presence of contractile reserve (n  63) was associated with
a significantly higher number of events (12.7%) compared with no change in wall motion score index (6.7%;
n  15; p  0.008).
Conclusions Myocardial infarct size on LGE MRI is a stronger predictor of clinical outcome than contractile reserve in medi-
cally treated patients with myocardial infarction. In patients with large myocardial scar, the presence of con-
tractile reserve is more important for the prediction of events than scar tissue. (J Am Coll Cardiol 2009;54:
1770–7) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.027e
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sn early studies, left ventricular ejection fraction (LVEF)
nd left ventricular end-systolic volume (LVESV) have been
emonstrated to be the strongest predictors of cardiac death
1,2). Preliminary findings in patients with acute myocardial
nfarction and moderate left ventricular (LV) dysfunction
howed that infarct size assessed with late gadolinium-
nhanced (LGE) magnetic resonance imaging (MRI) was a
etter predictor of adverse clinical outcome than LVEF (3).
In a previous study, it was shown that myocardial infarct
ize on LGE MRI, expressed as spatial extent, transmurality
f scar tissue, or total scar score is a stronger predictor of
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Manuscript received April 22, 2009; revised manuscript received July 13, 2009,
ccepted July 23, 2009.vents than LVEF and/or LV volumes in patients with
hronic myocardial infarction (4).
However, low-dose dobutamine stress testing with echo-
ardiography (5)—and more recently MRI—has been used
or many years to detect contractile reserve (indicating
ibernating myocardium) (6,7) and has been found to be
uperior for the prediction of functional recovery after
evascularization than LGE (8). The presence of contractile
eserve has also been demonstrated to have prognostic value:
ooled analysis of 11 studies using dobutamine echocardi-
graphy demonstrated that patients with contractile reserve
ho underwent revascularization had good clinical out-
ome, whereas patients with contractile reserve who were
reated medically had a high event rate (9). Information on
he relative merits of scar tissue and contractile reserve to
redict long-term prognosis in patients with chronic myo-
ardial infarction is lacking.
Accordingly, this study evaluated the relative merits of
car tissue on LGE MRI and contractile reserve on low-
ose dobutamine magnetic resonance (DSMR) for the
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November 3, 2009:1770–7 Infarct Size and Contractile Reserverediction of long-term outcome of patients with chronic
yocardial infarction who were treated medically.
ethods
tudy population and design. This was a prospective,
ollow-up study that involved 2 hospitals (German Heart
nstitute, Berlin, Germany and Leiden University Medical
enter, Leiden, the Netherlands). Consecutive patients
n 177) with chronic coronary artery disease were enrolled
etween 2000 and 2004, who were clinically referred for
RI to assess cardiac function, contractile reserve (using
ow-dose dobutamine), and the extent of scar tissue using
GE MRI (4). The patients in the current study were also
ncluded in a previous study evaluating the prognostic value
f infarct size relative to LV function/volumes (4), whereas
he current study evaluates the relative merits of hibernation
nd infarct size for prediction of prognosis. Patients with
yocardial infarction 3 months before cardiac MRI were
xcluded. Other exclusion criteria were contraindications for
RI (noncompatible biometallic implants or claustropho-
ia, known arrhythmias) or contraindications for adminis-
ration of dobutamine (severe arterial hypertension [220/
20 mm Hg], unstable angina pectoris, significant aortic
tenosis [aortic valve gradient 50 mm Hg or aortic valve
rea 1 cm2], complex cardiac arrhythmias, significant
ypertrophic obstructive cardiomyopathy, myocarditis, en-
ocarditis, and pericarditis) (10). The study was approved
y the local ethics committees of both institutions, and
nformed consent was obtained.
RI. A 1.5-T Gyroscan ACS-NT/Intera MRI scanner
Philips Healthcare, Best, the Netherlands) equipped with a
owertrack 6000 gradients and a 5-element cardiac synergy
oil was used in both institutions. Patients were positioned
n the supine position. Images were acquired during breath-
olds of approximately 15 s using vectorcardiography
ating.
The heart was imaged from apex to base, with 10 to 12
maging levels (dependent on the heart size) in the short-
xis view using a balanced, fast-field echo sequence with
arallel imaging (sensitivity encoding [SENSE], accelera-
ion factor 2). Typical parameters were a field of view of
00  400 mm2, matrix of 256  256 pixels, slice thickness
f 10.00 or 8.00 mm, no slice gap, flip angle of 50°, time to
cho of 1.82 ms, and time to repeat of 3.65 ms. Temporal
esolution was 25 to 39 ms.
Low-dose DSMR (continuous infusion of 10 g/kg
odyweight per minute for 3 min) was performed in every
atient. Magnetic resonance parameters were identical at
est and low-dose DSMR.
LGE images were acquired approximately 15 min after
olus injection of gadolinium diethylene triamine pentacetic
cid (Magnevist, Bayer-Schering, Berlin, Germany; 0.15
mol/kg [Leiden University Medical Center] or 0.20
mol/kg [German Heart Institute]) with an inversion-ecovery 3-dimensional spoiled gradient echo sequence; enversion time was determined
ith real-time plan scan. Typical
arameters were a field of view of
00  400 mm2, matrix of 256
256 pixels, slice thickness of
.00 mm, overlapping slices
50%), flip angle of 15°, time to
cho of 1.36 ms, and time to
epeat of 4.53 ms.
RI analysis. To determine
lobal function, endocardial bor-
ers were outlined manually on
hort-axis cine images with previ-
usly validated software (MASS,
edis, the Netherlands, or View-
orum, Philips Healthcare) (11).
apillary muscles were regarded as
art of the ventricular cavity, and
picardial fat was excluded.
VESV and left ventricular end-
iastolic volume (LVEDV) were calculated. Subsequently,
VESV was subtracted from LVEDV and LVEF was calcu-
ated. End-diastolic wall thickness was measured quantitatively
t the center of the infarct region.
For each of the 17 segments at rest and stress, LV wall
otion was assessed with a visual scoring system in which
 normal wall motion, 1  mild hypokinesia, 2  severe
ypokinesia, 3 akinesia, and 4 dyskinesia. Wall motion
core index (WMSI) during each stage of the protocol was
efined as the cumulative sum of individual segments scores
ivided by the number of interpreted segments. The change
delta) in WMSI and LV function from rest to low-dose
SMR was recorded. On a per-patient base, a decrease in
MSI was defined as contractile reserve (hibernation) and
n increase as ischemia.
LGE images were scored visually by 2 experienced
bservers (blinded to other MRI and clinical data) using a
7-segment model (12). Each segment was graded on a
-point scale (segmental scar score), with 0, absence of
yperenhancement; 1, hyperenhancement of 1% to 25% of
V wall thickness; 2, hyperenhancement extending from
6% to 50%; 3, hyperenhancement extending from 51% to
5%; and 4, hyperenhancement extending from 76% to
00% (13).
To quantify and define the extent/transmurality of scar
issue, the following definitions were used (14): 1) spatial
circumferential) extent, the number of affected segments;
) nontransmurality, the number of segments with a seg-
ental scar score of 1 or 2, and transmurality, the number
f segments with a segmental scar score of 3 or 4; and 3)
otal scar score, summed segmental scar scores per patient
ivided by 17 (which reflects the damage per patient).
ollow-up. The long-term follow-up was performed by
hart review and telephone contact. No patients were lost to
ollow-up. The primary end point was the occurrence of
Abbreviations
and Acronyms
CI  confidence interval
DSMR  dobutamine
magnetic resonance
LGE  late gadolinium
enhancement
LV  left ventricle/
ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
MRI  magnetic resonance
imaging
WMSI  wall motion score
indexvents, which were defined as cardiac death (caused by
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Infarct Size and Contractile Reserve November 3, 2009:1770–7nd-stage heart failure, acute myocardial infarction, or
udden cardiac death) and noncardiac death and nonfatal
yocardial infarction (4). Patients who underwent revascu-
arization after MRI were censored since the purpose of
his study was to determine the relative merits of scar tissue
nd contractile reserve in medically treated patients. Myo-
ardial infarction was defined by clinical presentation, ele-
ated cardiac enzyme levels, and/or typical changes on
lectrocardiography.
tatistical analysis. Statistical analysis was performed us-
ng SPSS for Windows (version 12.0.1, SPSS Inc., Chicago,
llinois). All continuous parameters are given as mean SD
r median (25% to 75% percentile). Categorical data are
ummarized as frequencies and percentages. Differences in
aseline characteristics between patients who reached the
rimary end point and those who did not were analyzed
sing Wilcoxon Mann-Whitney test for continuous vari-
bles and chi-square test for dichotomous variables.
We aimed to study to what extent MRI results were
ssociated with events. For this purpose, all MRI data with
value of p  0.1 (in a comparison between patients with
nd without the occurrence of events) were eligible. Cox
roportional hazards regression models were constructed for
RI variables, with spatial extent of scar as main exposure,
nd LVEF and LV dimensions, total number of dysfunc-
ional segments at rest, and WMSI at rest as confounding
actors. The latter variables appeared to be associated with
vents at a value of p  0.1 level in univariable analysis (and
e had to limit the number of covariables because of the
elatively small number of end point events). Unadjusted
nd adjusted hazard ratios with their corresponding 95%
Clinical DataTable 1 Clinical Data
Variable
Total Population
(n  177)
Age (yrs) 64 (57–68)
Men 155 (88%)
Diabetes mellitus 16%
Hypertension 58%
Hypercholesterolemia 85%
Smoker 49%
Previous Q-wave MI 54%
Extent of CAD (on angiogram)
1-vessel disease 13%
2-vessel disease 29%
3-vessel disease 58%
Medications
Beta-blocker 80%
Calcium channel blocker 22%
ACE inhibitor 78%
Aspirin/warfarin 99%
Statin 86%
Nitrate 32%
Diuretic 39%Continuous data are expressed as median (interquartile range); categorical d
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; MIonfidence intervals (CIs) are reported. To check the
roportional hazard assumption (i.e., that the hazard ratio
or 2 subjects with fixed predictors is constant over time)
og(_log[survival probability]) for different categories was
lotted against time to ensure that the curves were reason-
bly parallel. In general, all proportionality assumptions
ere appropriate. After adjustment for multiple confound-
rs (discussed in the previous text), spatial extent as deter-
ined by MRI appeared significantly related with events.
herefore, in a post-hoc analysis, the study population was
ivided into 2 groups, based on the observed median value
f the spatial extent of scar. Patients were stratified accord-
ng to a large extent of scar tissue (spatial extent 6
egments) or a small extent of scar tissue (spatial extent 6
egments) on LGE. The survival of both cohorts was
urther analyzed by the method of Kaplan-Meier. Differ-
nce in survival over time was evaluated by a log-rank test.
atients with 6 segments with scar (n  98) were
tratified according to transmurality of scar (more nontrans-
ural infarcted segments or more transmural infarcted
egments on LGE) and the presence of recruitable myocar-
ium (hibernation or ischemia) at low-dose dobutamine
timulation. The chi-square test was used to compare the
vent rates in both groups. For all tests, a value of p  0.05
as considered statistically significant. All tests were 2-sided.
esults
tudy population. Clinical data are presented in Table 1;
77 patients presenting LGE were included (n 111 at the
erman Heart Institute Berlin and n  66 at the Leiden
niversity Medical Center).
Events
p Value
Yes
(n  11)
No
(n  166)
67 (58–70) 64 (57–68) 0.306
10 (91%) 145 (87%) 0.731
27% 16% 0.316
27% 60% 0.032
64% 87% 0.036
46% 49% 0.831
55% 54% 0.989
0% 16%
30% 29% 0.196
70% 55%
73% 81% 0.522
36% 21% 0.231
64% 79% 0.239
100% 99% 0.798
46% 89% 0.001
27% 32% 0.785
73% 37% 0.018ata are expressed as percent of patients with complete data.
 myocardial infarction.
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November 3, 2009:1770–7 Infarct Size and Contractile Reservelinical outcome of patients during follow-up. The av-
rage duration of follow-up was 20.3  13.3 months,
edian: 18 months (10; 33); 11 patients (6.2%) suffered
rom an event during follow-up. Eight patients (4.5%) had
ardiac death, and noncardiac death was reported in 2
atients (1.1%). One patient (0.5%) developed myocardial
nfarction during follow-up. Furthermore, 11 patients
6.2%) were hospitalized during follow-up because of ven-
ricular arrhythmias (n  7, 4.0%) or unstable angina (n 
, 2.3%). Fifty-five patients (31.1%) underwent revascular-
zation after MRI and were censored at the time of
evascularization.
RI variables. MRI findings are listed in Table 2. Me-
ian LVEF in the total study population was 45% (25th to
5th percentile, 35% to 57%). LVEF was significantly
igher in patients without events than in patients with
vents. Median LVESV and LVEDV were significantly
ower in patients without events than in patients with
vents. No significant difference in end-diastolic wall thick-
ess values between patients without events and patients
ith events was detected. The WMSI was significantly
ower in patients without events than patients with events at
est, but not at low-dose dobutamine. We found no signif-
cant difference for change in WMSI between patients
ithout events and patients with events. The median spatial
xtent of scar tissue was significantly higher in patients with
vents than in patients without events.
redictors of events. As demonstrated in Table 1, hyper-
ension, hypercholesterolemia, and use of diuretics were
ignificantly higher in patients without events than in
atients with events, and the use of statins was less com-
on. Diuretic and statin usage were significantly associated
ith events (Table 3). However, neither diuretic usage, nor
tatin usage, was a true confounder for the relation between
patial extent of scar tissue and events (Table 4).
agnetic Resonance Imaging DataTable 2 Magnetic Resonance Imaging Data
Variable
Total Population
(n  177)
LV function
LVEF (%) 45 (35 to 57)
LVESV (ml) 101 (66 to 141)
LVEDV (ml) 186 (150 to 233)
End-diastolic wall thickness (mm) 4.3 (3.1 to 5.7)
No. of dysfunctional segments at rest 6 (3 to 8.5)
WMSI at rest 0.71 (0.29 to 1.06)
WMSI at stress 0.59 (0.24 to 1.06)
 WMSI 0.06 (0.23 to 0.00)
Scar
Spatial extent 6 (4 to 8)
Transmurality 3 (1 to 5)
Total scar score 0.76 (0.44 to 1.27)ata are expressed as median (interquartile range).
LVEDV  left ventricular end-diastolic volume; LVEF  left ventricular ejection fraction; LVESV  left veAs demonstrated in Table 3, LVESV, LVEDV, the
umber of dysfunctional segments at rest and WMSI at
est, but not at stress, and spatial extent of scar tissue were
ignificantly associated with events. LVEF was not related
ith the occurrence of events.
After adjustment for multiple (true or potential) con-
ounders (see the Methods section), infarct size defined as
patial extent remained the most important outcome deter-
inant (Table 5). Infarct size appears to be a stronger
redictor of events than LVEF and LV volumes.
Next, patients were separated according to the extent of
car (patients with large myocardial infarction  patients at
igh risk, spatial extent 6 segments, n  98) and were
ompared with patients with small myocardial infarction 
atients at low risk (spatial extent6 segments, n 79) for
Events
p Value
Yes
(n  11)
No
(n  166)
40 (21 to 46) 45 (35 to 58) 0.026
133 (102 to 294) 98 (65 to 138) 0.002
225 (173 to 372) 184 (149 to 230) 0.004
5 (2.4 to 5.8) 4.3 (3.1 to 5.7) 0.786
10 (6 to 13) 5 (3 to 8) 0.003
1.06 (0.47 to 1.65) 0.65 (0.29 to 1.06) 0.017
0.94 (0.29 to 1.53) 0.59 (0.23 to 1.06) 0.067
0.12 (0.29 to 0.06) 0.06 (0.19 to 0.00) 0.134
8 (6 to 13) 6 (4 to 7) 0.001
3 (1 to 8) 3 (1 to 5) 0.277
1 (0.53 to 1.65) 0.76 (0.41 to 1.23) 0.195
nivariate Analysis for Prediction of EventsTable 3 Univariate Analysis for Prediction of Events
MRI Variable
Hazard
Ratio
95% Confidence
Interval p Value
LV function
LVEF (%) 0.966 0.925–1.009 0.117
LVESV (ml) 1.007 1.001–1.013 0.032
LVEDV (ml) 1.007 1.000–1.014 0.044
No. of dysfunctional segments 1.178 1.017–1.363 0.029
WMSI at rest 3.077 1.087–8.707 0.034
WMSI at stress 2.796 0.903–8.658 0.075
Scar
Spatial extent 1.271 1.064–1.518 0.008
Clinical variables
Hypertension 2.475 0.649–9.435 0.184
Hypercholesterolemia 3.251 0.945–11.178 0.061
Medications
Diuretics 5.259 1.390–19.898 0.014
Statins 0.166 0.050–0.548 0.003
values are unadjusted.
Abbreviations as in Table 2.ntricular end-systolic volume; WMSI  wall motion score index.
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Infarct Size and Contractile Reserve November 3, 2009:1770–7vents. The 4-year cumulative event rate was significantly
igher in patients with a spatial extent of scar 6 segments
p  0.03) (Fig. 1).
In the patient group at high risk for events (spatial extent
f scar 6 segments), those with more nontransmural
nfarcted segments had a nonsignificant higher event-rate
12.5%, n  40) than those with more transmural infarcted
egments (8.6%, n 58) (p 0.53). However, the presence
f contractile reserve during low-dose dobutamine (n  63)
as associated with a significantly higher number of events
12.7%) compared with no change in WMSI (6.7%, n 15,
 0.008) or increase in WMSI (ischemia) (5.0%, n  20,
 0.008). At univariate analysis, contractile reserve was
he only predictor of events in this patient population
chi-square 4.0, 95% CI: 1.1 to 15.1, p  0.04), whereas
schemia, no response to low-dose DSMR, and scar trans-
urality did not predict outcome (chi-square 0.7, 95% CI:
.1 to 5.8, p  0.08; chi-square 0.8, 95% CI: 0.1 to 6.2,
 0.8; chi-square 2.1, 95% CI: 0.6 to 6.7, p  0.2
nontransmural scar]; and chi-square 2.0, 95% CI: 0.6 to
.4, p  0.3 [transmural scar], respectively). The chi-square
alue was not significantly different between patients with
ore nontransmural infarcted segments and patients with
ore transmural infarcted segments (p  NS). However,
he chi-square value was significantly higher in patients
howing contractile reserve as compared with ischemia (p
.001) or no response (p  0.001) during low-dose dobut-
mine stimulation (Fig. 2).
iscussion
he main finding in this study is that myocardial infarct size
n LGE MRI is a stronger predictor of clinical outcome
elation Between Diuretic Usage, Statin Usage, andnfarct Siz (Spatial Extent of Scar Tissue)n LGE MRI
Table 4
R l ion Between Diure ic Usage, St tin Usage,
and Infarct Size (Spatial Extent of Scar Tissue)
on LGE MRI
Scar
Patients Using
Diuretics
Patients Not
Using Diuretics p Value
Spatial extent 7 (4–9) 5 (3–7) 0.116
Patients Using
Statins
Patients Not
Using Statins
Spatial extent 6 (4–8) 6 (4–9) 0.536
ata are expressed as median (interquartile range).
ultivariable Cox Proportionalazard Mod l f r Prediction of EventsTable 5 Multiva iable Cox ProportionalHazard Model for Prediction of Events
MRI Variable
Hazard
Ratio
95% Confidence
Interval p Value
Scar spatial extent 1.303 1.026–1.655 0.030
LVEF (%) at rest 1.102 0.972–1.250 0.130
LVESV (ml) at rest 1.029 0.980–1.080 0.252
LVEDV (ml) at rest 0.987 0.949–1.026 0.501
his model is using the spatial extent as variable of scar tissue on late gadolinium-enhancedp
agnetic resonance imaging.
Abbreviations as in Table 2.han contractile reserve (hibernation) on low-dose DSMR
n medically treated patients with chronic myocardial in-
arction. In patients with large myocardial scar, however, the
resence of contractile reserve on low-dose DSMR is more
mportant for the prediction of events than scar tissue on
GE MRI.
mportance of scar tissue. There is growing clinical evi-
ence that tissue characterization with LGE MRI provides
nformation valuable to patient outcome (15). Separate
linical reports demonstrate the unique and important
rognostic value of microvascular obstruction identified on
GE imaging in patients who experienced a recent myo-
ardial infarction (16,17). Wu et al. (16) studied patients
ith acute myocardial infarction and demonstrated that
nfarct size determined by LGE MRI directly relates to
ong-term prognosis in contrast to LV volumes and LVEF.
ssessment of infarct size using LGE MRI can also predict
unctional recovery after acute myocardial infarction: Gerber
t al. (18) evaluated 20 patients after acute myocardial
nfarction with LGE MRI and myocardial tagging and
oted that improvement in circumferential shortening was
nversely related to the regional extent of hyperenhancement
n LGE images.
The prognostic value of infarct size has also been dem-
nstrated in patients with chronic myocardial infarction. In
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Follow-up (minths)
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Figure 1 Prognostic Value of Myocardial Infarct Size
Kaplan-Meier curve analysis (48 months) showing the difference in cumulative
event rate when patients are stratified according to a large extent of scar tis-
sue (spatial extent 6 segments) or a small extent of scar tissue (spatial
extent 6 segments) on late gadolinium-enhanced magnetic resonance imag-
ing. p  0.03.revious work, we demonstrated in 231 patients with
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November 3, 2009:1770–7 Infarct Size and Contractile Reservehronic myocardial infarction that the extent of scar tissue
n LGE MRI was a stronger predictor of events than LV
unction and/or dimensions (4).
In addition, recent data have identified scar tissue and
everely depressed LVEF as important predictors of death
r ventricular arrhythmias in patients with coronary artery
isease (19). Bello et al. (20) showed that infarct size,
etermined with LGE MRI was superior to LVEF for
dentification of patients with a substrate for inducible
entricular tachycardia. Yan et al. (21) demonstrated that
he extent of the peri-infarct zone characterized by LGE
RI provides incremental prognostic value beyond LVEF
nd LVESV. Another study in patients with chronic myo-
ardial infarction found that infarct heterogeneity on LGE
RI was strongly related to inducibility for monomorphic
entricular tachycardia during electrophysiological or device
esting (22).
Furthermore, LGE MRI was able to characterize occult
yocardial scar consistent with myocardial infarction in
iabetic patients without clinical evidence of myocardial
nfarction and provided significant prognostic value (23).
inally, Kim et al. (24) studied 185 patients with suspected
oronary artery disease but without a history of clinical
yocardial infarction using MRI and showed that the
resence of non–Q-wave myocardial infarction was a strong
redictor of mortality.
mportance of contractile reserve (hibernation). Low-
ose DSMR enables detection of hibernation by assessment
f contractile reserve in dysfunctional segments in response
o dobutamine stimulation. Previous studies reported on the
redictive value of low-dose DSMR for functional recovery
Figure 2 Prognostic Value: Contractile Reserve Versus Infarct
Bar graphs illustrating the incremental prognostic value (depicted by chi-square va
y-axis) of low-dose dobutamine in patients with large myocardial infarction (6 segn patients with acute myocardial infarction (7,25). Dendale tt al. (7) studied 26 patients with an acute myocardial
nfarction using low-dose DSMR and concluded that the
resence of contractile reserve predicts recovery of function
fter revascularization with 80% accuracy. Baer et al. (26,27)
valuated this technique in patients with chronic myocardial
nfarction and demonstrated that low-dose DSMR can also
dequately predict improvement of LV function after
evascularization.
However, information on the predictive value of low-dose
SMR for clinical outcome in patients with depressed
VEF is lacking. Nonetheless, previous 2-dimensional
chocardiographic studies using low-dose dobutamine stim-
lation demonstrated that the presence of contractile reserve
n patients with chronic myocardial infarction relates to
ong-term prognosis (28–30). Rizzello et al. (28) studied
28 patients with chronic myocardial infarction using echo-
ardiography and undergoing revascularization and con-
luded that the presence of contractile reserve was associated
ith a favorable prognosis after revascularization. In addi-
ion, Sawada et al. (31) reported in 98 patients who
nderwent low-dose dobutamine echocardiography and
ubsequent revascularization that patients with larger areas
ith contractile reserve had favorable clinical outcome.
urthermore, multivariable analysis showed that the extent
f contractile reserve had incremental prognostic value for
ong-term clinical outcome over clinical information and
esting LV function.
A pooled analysis of 11 studies using dobutamine echo-
ardiography (9) demonstrated that patients with contractile
eserve who underwent revascularization had a good prog-
osis (annual event rate 6%), whereas patients with contrac-
the
with scar).Size
lue on
mentsile reserve who were treated medically had a poor outcome
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Infarct Size and Contractile Reserve November 3, 2009:1770–7annual event rate 17%). These results indicate that revas-
ularization of hibernating myocardium may prevent future
schemic events or ventricular arrhythmias (9). Alterna-
ively, patients with hibernating myocardium who are
reated medically are at high risk for events. The results of
he present study confirm that the presence of contractile
eserve (hibernation) in medically treated patients with large
yocardial infarction is associated with a significantly
igher event rate compared with patients without contrac-
ile reserve.
car tissue versus contractile reserve. Kaandorp et al. (32)
erformed a head-to-head comparison between LGE and
ow-dose DSMR in 48 patients with chronic myocardial
nfarction and observed that the majority of segments with
inimal scar tissue on LGE MRI showed contractile
eserve on low-dose DSMR, whereas contractile reserve was
ractically absent in segments with transmural scar tissue on
GE MRI. However, in segments with an intermediate
mount of scar tissue, an intermediate proportion of the
egments (42%) showed contractile reserve during low-dose
SMR, suggesting additional value of low-dose DSMR for
rediction of functional recovery in these segments. Indeed,
ellnhofer et al. (8) studied 29 patients with chronic
yocardial infarction before and after revascularization and
emonstrated that assessment of contractile reserve with
ow-dose DSMR was superior to scar quantification for the
rediction of functional recovery, especially in segments
ith nontransmural scar tissue.
Until now, however, information on the relative value of
car tissue and contractile reserve (using LGE MRI and
ow-dose DSMR) for the prediction of clinical outcome was
acking. The results of the present study suggest that scar
issue (on LGE MRI) is more important than contractile
eserve on low-dose DSMR for the prediction of events in
edically treated patients with chronic myocardial infarc-
ion. However, in patients with large myocardial scar,
ontractile reserve (hibernation) is a better predictor of
vents than scar tissue on LGE MRI.
tudy limitations. A limitation of the present study is that
he extent of myocardial ischemia was not evaluated using
igh-dose dobutamine magnetic resonance. Accordingly,
urther MRI studies are needed to assess the prognostic
alue of integrated assessment of ischemia using high-dose
obutamine stimulation, hibernation, and scar tissue. Fur-
hermore, segmental wall motion was visually analyzed, and
dditional studies evaluating myocardial strain using quan-
itative assessment of wall motion by MRI tagging com-
ined with rapid post-processing algorithms may overcome
his limitation (33,34). In addition, myocardial strain may
ave prognostic value since strain assessment enables eval-
ation of border zone function, which has been related to
nducibility of monomorphic ventricular tachycardia (35).
urthermore, the small number of events in patients with
mall myocardial infarcts (6 segments) limits the evalua-
ion of the prognostic value of hibernation relative to scar
ransmurality in these patients. Larger studies with subse-uently higher event rates are needed to clarify the relative
erits of scar transmurality and hibernation in patients with
mall myocardial infarcts. Finally, evaluation of infarct
issue heterogeneity using LGE MRI (21,22,36) also en-
bles prediction of events, and future studies are needed to
valuate the prognostic value of infarct tissue heterogeneity
ompared with hibernation and total infarct size.
onclusions
yocardial infarct size on LGE MRI is a stronger predictor
f clinical outcome than contractile reserve on low-dose
SMR in medically treated patients with chronic myocar-
ial infarction. In patients with large myocardial scar,
owever, the presence of contractile reserve (hibernation) is
ore important for the prediction of events than scar tissue.
arger studies are needed to confirm the results of the
resent study.
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